Platelet transfusion refractoriness (PTR), defined as an unsatisfactory post‐transfusion platelet count increment, is a common complication of patients receiving multiple transfusions. Different strategies are described in the management of PTR. In this work, we demonstrate the efficacy of the detection and identification of anti‐HLA antibodies in the recipient using a threshold of 3000 mean fluorescence intensity (MFI), and the seek of donors not expressing HLA antigens against which the patient is immunized.

participated in data analysis. Mamy Ralazamahaleo, Marine Cargou and Richard Lemal were involved in critical revision of the manuscript.

HLA‐A*29:02:38 differs from HLA‐A*29:02:01:01 by one nucleotide substitution in codon 201 in exon 4.

HLA‐C*04:451 differs from HLA‐C*04:01:01:01 by one nucleotide substitution in codon 229 in exon 4.

HLA‐DQA1*01:01:10 differs from HLA‐DQA1*01:01:01:01 by a single nucleotide change in codon 7 in exon 2.